Benzinga | Nov 19, 2021 08:58AM EST

Northland Capital Markets Downgrades Flexion Therapeutics to Market Perform

Northland Capital Markets analyst Carl Byrnes downgrades Flexion Therapeutics (NASDAQ:FLXN) from Outperform to Market Perform.